FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:MTA3-ATXN2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: MTA3-ATXN2
FusionPDB ID: 55491
FusionGDB2.0 ID: 55491
HgeneTgene
Gene symbol

MTA3

ATXN2

Gene ID

57504

6311

Gene namemetastasis associated 1 family member 3ataxin 2
Synonyms-ATX2|SCA2|TNRC13
Cytomap

2p21

12q24.12

Type of geneprotein-codingprotein-coding
Descriptionmetastasis-associated protein MTA3metastasis associated gene family, member 3ataxin-2spinocerebellar ataxia type 2 proteintrinucleotide repeat-containing gene 13 protein
Modification date2020031320200313
UniProtAcc

Q9BTC8

Main function of 5'-partner protein: FUNCTION: Plays a role in maintenance of the normal epithelial architecture through the repression of SNAI1 transcription in a histone deacetylase-dependent manner, and thus the regulation of E-cadherin levels. Contributes to transcriptional repression by BCL6. {ECO:0000269|PubMed:12705869, ECO:0000269|PubMed:15454082}.

Q8WWM7

Main function of 5'-partner protein: FUNCTION: Involved in the regulation of stress granule and P-body formation. {ECO:0000269|PubMed:23209657}.
Ensembl transtripts involved in fusion geneENST idsENST00000405094, ENST00000405592, 
ENST00000406652, ENST00000406911, 
ENST00000407270, ENST00000472767, 
ENST00000549455, ENST00000377617, 
ENST00000389153, ENST00000535949, 
ENST00000542287, ENST00000550104, 
ENST00000608853, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score10 X 10 X 3=30021 X 19 X 10=3990
# samples 1127
** MAII scorelog2(11/300*10)=-1.44745897697122
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(27/3990*10)=-3.88535743405888
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: MTA3 [Title/Abstract] AND ATXN2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: MTA3 [Title/Abstract] AND ATXN2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)MTA3(42806340)-ATXN2(111908546), # samples:1
Anticipated loss of major functional domain due to fusion event.MTA3-ATXN2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
MTA3-ATXN2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:42806340/chr12:111908546)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across MTA3 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ATXN2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000405592MTA3chr242806340+ENST00000389153ATXN2chr12111908546-22346926701635321
ENST00000405592MTA3chr242806340+ENST00000608853ATXN2chr12111908546-22346926701635321
ENST00000405592MTA3chr242806340+ENST00000377617ATXN2chr12111908546-22346926701635321
ENST00000405592MTA3chr242806340+ENST00000550104ATXN2chr12111908546-21806926701635321
ENST00000405592MTA3chr242806340+ENST00000542287ATXN2chr12111908546-17696926701710346
ENST00000405592MTA3chr242806340+ENST00000535949ATXN2chr12111908546-16406926701581303
ENST00000406652MTA3chr242806340+ENST00000389153ATXN2chr12111908546-18863441391287382
ENST00000406652MTA3chr242806340+ENST00000608853ATXN2chr12111908546-18863441391287382
ENST00000406652MTA3chr242806340+ENST00000377617ATXN2chr12111908546-18863441391287382
ENST00000406652MTA3chr242806340+ENST00000550104ATXN2chr12111908546-18323441391287382
ENST00000406652MTA3chr242806340+ENST00000542287ATXN2chr12111908546-14213441391362407
ENST00000406652MTA3chr242806340+ENST00000535949ATXN2chr12111908546-12923441391233364
ENST00000407270MTA3chr242806340+ENST00000389153ATXN2chr12111908546-1961419191362447
ENST00000407270MTA3chr242806340+ENST00000608853ATXN2chr12111908546-1961419191362447
ENST00000407270MTA3chr242806340+ENST00000377617ATXN2chr12111908546-1961419191362447
ENST00000407270MTA3chr242806340+ENST00000550104ATXN2chr12111908546-1907419191362447
ENST00000407270MTA3chr242806340+ENST00000542287ATXN2chr12111908546-1496419191437472
ENST00000407270MTA3chr242806340+ENST00000535949ATXN2chr12111908546-1367419191308429
ENST00000406911MTA3chr242806340+ENST00000389153ATXN2chr12111908546-180326121204400
ENST00000406911MTA3chr242806340+ENST00000608853ATXN2chr12111908546-180326121204400
ENST00000406911MTA3chr242806340+ENST00000377617ATXN2chr12111908546-180326121204400
ENST00000406911MTA3chr242806340+ENST00000550104ATXN2chr12111908546-174926121204400
ENST00000406911MTA3chr242806340+ENST00000542287ATXN2chr12111908546-133826121279425
ENST00000406911MTA3chr242806340+ENST00000535949ATXN2chr12111908546-120926121150382
ENST00000405094MTA3chr242806340+ENST00000389153ATXN2chr12111908546-173219001133377
ENST00000405094MTA3chr242806340+ENST00000608853ATXN2chr12111908546-173219001133377
ENST00000405094MTA3chr242806340+ENST00000377617ATXN2chr12111908546-173219001133377
ENST00000405094MTA3chr242806340+ENST00000550104ATXN2chr12111908546-167819001133377
ENST00000405094MTA3chr242806340+ENST00000542287ATXN2chr12111908546-126719001208402
ENST00000405094MTA3chr242806340+ENST00000535949ATXN2chr12111908546-113819001079359

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000405592ENST00000389153MTA3chr242806340+ATXN2chr12111908546-0.0457945020.9542056
ENST00000405592ENST00000608853MTA3chr242806340+ATXN2chr12111908546-0.0457945020.9542056
ENST00000405592ENST00000377617MTA3chr242806340+ATXN2chr12111908546-0.0457945020.9542056
ENST00000405592ENST00000550104MTA3chr242806340+ATXN2chr12111908546-0.0379602420.9620398
ENST00000405592ENST00000542287MTA3chr242806340+ATXN2chr12111908546-0.0341531080.9658469
ENST00000405592ENST00000535949MTA3chr242806340+ATXN2chr12111908546-0.0352886950.96471137
ENST00000406652ENST00000389153MTA3chr242806340+ATXN2chr12111908546-0.0178882010.9821118
ENST00000406652ENST00000608853MTA3chr242806340+ATXN2chr12111908546-0.0178882010.9821118
ENST00000406652ENST00000377617MTA3chr242806340+ATXN2chr12111908546-0.0178882010.9821118
ENST00000406652ENST00000550104MTA3chr242806340+ATXN2chr12111908546-0.01344920.9865508
ENST00000406652ENST00000542287MTA3chr242806340+ATXN2chr12111908546-0.0092659210.9907341
ENST00000406652ENST00000535949MTA3chr242806340+ATXN2chr12111908546-0.0080954450.9919045
ENST00000407270ENST00000389153MTA3chr242806340+ATXN2chr12111908546-0.0038872710.99611276
ENST00000407270ENST00000608853MTA3chr242806340+ATXN2chr12111908546-0.0038872710.99611276
ENST00000407270ENST00000377617MTA3chr242806340+ATXN2chr12111908546-0.0038872710.99611276
ENST00000407270ENST00000550104MTA3chr242806340+ATXN2chr12111908546-0.0042627280.9957373
ENST00000407270ENST00000542287MTA3chr242806340+ATXN2chr12111908546-0.008270760.9917292
ENST00000407270ENST00000535949MTA3chr242806340+ATXN2chr12111908546-0.008501650.9914983
ENST00000406911ENST00000389153MTA3chr242806340+ATXN2chr12111908546-0.0026081960.9973918
ENST00000406911ENST00000608853MTA3chr242806340+ATXN2chr12111908546-0.0026081960.9973918
ENST00000406911ENST00000377617MTA3chr242806340+ATXN2chr12111908546-0.0026081960.9973918
ENST00000406911ENST00000550104MTA3chr242806340+ATXN2chr12111908546-0.0024945940.9975055
ENST00000406911ENST00000542287MTA3chr242806340+ATXN2chr12111908546-0.0046858320.9953141
ENST00000406911ENST00000535949MTA3chr242806340+ATXN2chr12111908546-0.0043666770.9956333
ENST00000405094ENST00000389153MTA3chr242806340+ATXN2chr12111908546-0.0022708120.99772924
ENST00000405094ENST00000608853MTA3chr242806340+ATXN2chr12111908546-0.0022708120.99772924
ENST00000405094ENST00000377617MTA3chr242806340+ATXN2chr12111908546-0.0022708120.99772924
ENST00000405094ENST00000550104MTA3chr242806340+ATXN2chr12111908546-0.0022277220.9977723
ENST00000405094ENST00000542287MTA3chr242806340+ATXN2chr12111908546-0.0034632050.99653685
ENST00000405094ENST00000535949MTA3chr242806340+ATXN2chr12111908546-0.0030813090.9969187

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for MTA3-ATXN2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
MTA3chr242806340ATXN2chr1211190854619062DISNTLIMLADKHAIPNMPQQRQDQH
MTA3chr242806340ATXN2chr1211190854626185DISNTLIMLADKHAIPNMPQQRQDQH
MTA3chr242806340ATXN2chr1211190854634467DISNTLIMLADKHAIPNMPQQRQDQH
MTA3chr242806340ATXN2chr12111908546419132DISNTLIMLADKHAIPNMPQQRQDQH

Top

Potential FusionNeoAntigen Information of MTA3-ATXN2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MTA3-ATXN2_42806340_111908546.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MTA3-ATXN2chr242806340chr12111908546190HLA-B08:01MLADKHAI0.99780.6505715
MTA3-ATXN2chr242806340chr12111908546190HLA-B08:09MLADKHAI0.99720.6283715
MTA3-ATXN2chr242806340chr12111908546190HLA-A02:19IMLADKHAI0.79680.5138615
MTA3-ATXN2chr242806340chr12111908546190HLA-A68:06HAIPNMPQQR0.97990.62051222
MTA3-ATXN2chr242806340chr12111908546190HLA-A68:24HAIPNMPQQR0.97850.74181222
MTA3-ATXN2chr242806340chr12111908546190HLA-A66:01HAIPNMPQQR0.9760.69281222
MTA3-ATXN2chr242806340chr12111908546190HLA-A68:03HAIPNMPQQR0.97420.73141222
MTA3-ATXN2chr242806340chr12111908546190HLA-A34:01HAIPNMPQQR0.95140.64651222
MTA3-ATXN2chr242806340chr12111908546190HLA-A34:05HAIPNMPQQR0.95140.64651222
MTA3-ATXN2chr242806340chr12111908546190HLA-A68:05HAIPNMPQQR0.94890.73891222
MTA3-ATXN2chr242806340chr12111908546190HLA-A68:08HAIPNMPQQR0.92570.66161222
MTA3-ATXN2chr242806340chr12111908546190HLA-A26:03HAIPNMPQQR0.91960.70171222
MTA3-ATXN2chr242806340chr12111908546190HLA-A66:03HAIPNMPQQR0.8870.59461222
MTA3-ATXN2chr242806340chr12111908546190HLA-A33:05HAIPNMPQQR0.75410.6291222
MTA3-ATXN2chr242806340chr12111908546190HLA-A33:01HAIPNMPQQR0.75410.6291222
MTA3-ATXN2chr242806340chr12111908546190HLA-A02:04MLADKHAIPNM0.99250.7647718
MTA3-ATXN2chr242806340chr12111908546190HLA-A68:01HAIPNMPQQR0.97850.74181222
MTA3-ATXN2chr242806340chr12111908546190HLA-B08:18MLADKHAI0.99780.6505715
MTA3-ATXN2chr242806340chr12111908546190HLA-B08:12MLADKHAI0.95970.7594715
MTA3-ATXN2chr242806340chr12111908546190HLA-A66:02HAIPNMPQQR0.90780.55421222

Top

Potential FusionNeoAntigen Information of MTA3-ATXN2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MTA3-ATXN2_42806340_111908546.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MTA3-ATXN2chr242806340chr12111908546190DRB1-0415SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-0415ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-0436SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-0436ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-0437SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-0440SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-0442SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-0442ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-0444SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-0453SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-0453ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-0455SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-0456SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-0456ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-0458SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-0458ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-0468SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-0470SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-0473SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-0479SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1113SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1113NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1117SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1117NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1117ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1134SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1152SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1152NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1152ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1189SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1189NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1192SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1204SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1209SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1220SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1309SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1331SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1331NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1343SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1343NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1344SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1354SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1354NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1376SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1376NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1377SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1377NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1377ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1401SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1401NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1401ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1404SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1404NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1404ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1405SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1405NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1405ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1406SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1407SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1407NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1408SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1408NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1408ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1411SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1411NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1411ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1412SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1414SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1416SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1416NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1417SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1418SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1418NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1418ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1420SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1423SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1423NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1423ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1426SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1426NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1426ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1428SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1428NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1428ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1429SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1429NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1431SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1431NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1431ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1432SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1432NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1432ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1433SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1433NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1434SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1434NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1435SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1435NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1435ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1436SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1437SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1438SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1438NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1438ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1439SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1439NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1439ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1442SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1443SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1443NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1443ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1444SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1445SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1445NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1445ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1450SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1450NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1450ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1452SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1454SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1454NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1454ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1455SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1455NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1455ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1456SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1456NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1456ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1458SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1458NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1458ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1459SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1459NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1459ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1460SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1460NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1460ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1461SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1461NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1461ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1462SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1462NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1462ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1464SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1464NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1464ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1465SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1465NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1468SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1468NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1470SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1470NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1470ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1471SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1471NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1471ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1472SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1472NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1472ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1473SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1473NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1474SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1475SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1475NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1475ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1481SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1481NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1482SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1482NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1482ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1483SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1486SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1486NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1486ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1487SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1487NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1487ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1488SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1488NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1488ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1490SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1490NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1490ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1491SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1491NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1491ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1493SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1495SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1495NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1495ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1496SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1496NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1496ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1497SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1497NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1497ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1499SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1499NTLIMLADKHAIPNM318
MTA3-ATXN2chr242806340chr12111908546190DRB1-1499ISNTLIMLADKHAIP116
MTA3-ATXN2chr242806340chr12111908546190DRB1-1615SNTLIMLADKHAIPN217
MTA3-ATXN2chr242806340chr12111908546190DRB1-1615ISNTLIMLADKHAIP116

Top

Fusion breakpoint peptide structures of MTA3-ATXN2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3840IMLADKHAIPNMPQMTA3ATXN2chr242806340chr12111908546190

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of MTA3-ATXN2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3840IMLADKHAIPNMPQ-7.15543-7.26883
HLA-B14:023BVN3840IMLADKHAIPNMPQ-4.77435-5.80965
HLA-B52:013W393840IMLADKHAIPNMPQ-6.80875-6.92215
HLA-B52:013W393840IMLADKHAIPNMPQ-4.20386-5.23916
HLA-A11:014UQ23840IMLADKHAIPNMPQ-7.5194-8.5547
HLA-A11:014UQ23840IMLADKHAIPNMPQ-6.9601-7.0735
HLA-A24:025HGA3840IMLADKHAIPNMPQ-7.52403-7.63743
HLA-A24:025HGA3840IMLADKHAIPNMPQ-5.82433-6.85963
HLA-B27:056PYJ3840IMLADKHAIPNMPQ-3.28285-4.31815
HLA-B44:053DX83840IMLADKHAIPNMPQ-5.91172-6.94702
HLA-B44:053DX83840IMLADKHAIPNMPQ-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of MTA3-ATXN2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
MTA3-ATXN2chr242806340chr121119085461222HAIPNMPQQRCTATACCAAATATGCCCCAACAGCGGCAAG
MTA3-ATXN2chr242806340chr12111908546615IMLADKHAITGCTCGCAGATAAGCATGCTATACCAA
MTA3-ATXN2chr242806340chr12111908546715MLADKHAITCGCAGATAAGCATGCTATACCAA
MTA3-ATXN2chr242806340chr12111908546718MLADKHAIPNMTCGCAGATAAGCATGCTATACCAAATATGCCCC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
MTA3-ATXN2chr242806340chr12111908546116ISNTLIMLADKHAIPCCAACACACTTATAATGCTCGCAGATAAGCATGCTATACCAAATA
MTA3-ATXN2chr242806340chr12111908546217SNTLIMLADKHAIPNACACACTTATAATGCTCGCAGATAAGCATGCTATACCAAATATGC
MTA3-ATXN2chr242806340chr12111908546318NTLIMLADKHAIPNMCACTTATAATGCTCGCAGATAAGCATGCTATACCAAATATGCCCC

Top

Information of the samples that have these potential fusion neoantigens of MTA3-ATXN2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADMTA3-ATXN2chr242806340ENST00000405094chr12111908546ENST00000377617TCGA-CD-A486-01A

Top

Potential target of CAR-T therapy development for MTA3-ATXN2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to MTA3-ATXN2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to MTA3-ATXN2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource